Company | Stem Cell Therapy

OUR COMPANY

We are an A*STAR spin-off focused on future-relevant solutions in this new era of regenerative science.

THE CELLIGENICS STORY

Celligenics is a biotechnology company specialised in the development of future-relevant solutions using breakthrough stem cell technology developed by the National University of Singapore.

We believe that we have the means to empower humanity by unlocking a new generation of lifesaving and life-enhancing products – for healthcare, beauty and beyond.

Collectively, our core expertise spans across investment finance, enterprise strategy and product development, as well as experience in the field of working with molecular and cell biology.

OUR CORE VALUES

To Serve With A Commitment -

to professionalism, integrity

& passion

OUR MISSION

To Be A Leader -

in the innovative isolation & application of human stem cells & deliverables

OUR VISION

To Empower People -

with regenerative healthcare solutions that will enhance the quality of human life

OUR CORE

STRENGTHS

Diversified biotechnology company engaged in multiple inter-related businesses, allowing a synergistic effect.

Ownership of several patents and licences, with some ready to commence clinical trials.

Major emphasis on research & development as a core of the company's enterprise strategy.

Strategic partnerships with established companies and reputable research and academic institutions.

Experienced management team with strong credentials in the dual-facet of enterprise management and scientific research.

BOARD OF DIRECTORS

HUANG BAN CHIN

Director

Celligenics

Chief Operating Officer

Best World International

KOH CHOON HUI

Chairman

Celligenics

Chairman

Singapore Pools

Former Managing Director

Roche International

KURT WEE

Director

Celligenics

President

Association of Small & Medium Enterprises

Chairman

Singapore Business Federation SME Committee

SPECIAL ADVISORY BOARD

SHIGEKI SUGII

A*STAR

Group Leader

Singapore Bio-imaging Consortium

(Agency for Science, Technology, & Research)

Assistant Professor

Cardiovascular & Metabolic Disorders Programme

(Duke-NUS Medical School)

CORE TEAM

KURT WEE

Chief Executive Officer

NICOLE TSANG

Head, Product Development

PAULINE TAY

Chief Operating Officer

WINSTON LUMENTA

Head, Corporate

PAMELA MOK

Head, Research & Labs

HUEY LIN

Deputy Head, Business Development

OUR COMPANY

We are an A*STAR spin-off focused on future-relevant solutions in this new era of regenerative science.

​

​

THE CELLIGENICS STORY

​

OUR CORE VALUES

​

To Serve With A Commitment -

to professionalism, integrity

& passion

​

OUR MISSION

​

To Be A Leader -

in the innovative isolation & application of human stem cells & deliverables

​

OUR VISION

​

To Empower People -

with regenerative healthcare solutions that will enhance the quality of human life

​

OUR CORE

STRENGTHS

Diversified biotechnology company engaged in multiple inter-related businesses, allowing a synergistic effect.

​

​

Ownership of several patents and licences, with some ready to commence clinical trials.

​

​

Major emphasis on research & development as a core of the company's enterprise strategy.

​

​

Strategic partnerships with established companies and reputable research and academic institutions.

​

​

Experienced management team with strong credentials in the dual-facet of enterprise management and scientific research.

​

​

​

​

BOARD OF DIRECTORS

​

HUANG BAN CHIN

​

Director

Celligenics

​

Chief Operating Officer

Best World International

KOH CHOON HUI

​

Chairman

Celligenics

​

Chairman

Singapore Pools

​

Former Managing Director

Roche International

​

KURT WEE

​

Director

Celligenics

​

President

Association of Small & Medium Enterprises

​

Chairman

Singapore Business Federation SME Committee

​

​

​

​

SPECIAL ADVISORY BOARD

​

SHIGEKI SUGII

A*STAR

​

+65 6538 6211 (Fax)